BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22108866)

  • 1. Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells.
    Amsterdam A; Shezen E; Raanan C; Schreiber L; Slilat Y; Fabrikant Y; Melzer E; Seger R
    Int J Oncol; 2012 Mar; 40(3):782-8. PubMed ID: 22108866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two initiation sites of early detection of colon cancer revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of the tumor cells.
    Amsterdam A; Shezen E; Raanan C; Schreiber L; Slilat Y; Fabrikant Y; Melzer E; Seger R
    Acta Histochem; 2013 Jul; 115(6):569-76. PubMed ID: 23357054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of multiple biomarkers for the localization and characterization of colon cancer stem cells by indirect immunocytochemistry.
    Amsterdam A; Raanan C; Schreiber L; Freyhan O; Fabrikant Y; Melzer E
    Int J Oncol; 2012 Jul; 41(1):285-91. PubMed ID: 22504585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of phosphorylated ERK1 and ERK2 as markers for the progression of ovarian cancer.
    Amsterdam A; Shezen E; Raanan C; Schreiber L; Prus D; Slilat Y; Ben-Arie A; Seger R
    Int J Oncol; 2011 Sep; 39(3):649-56. PubMed ID: 21687944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells.
    Amsterdam A; Raanan C; Schreiber L; Freyhan O; Fabrikant Y; Melzer E; Givol D
    Acta Histochem; 2013 May; 115(4):320-9. PubMed ID: 23098761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
    Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
    Al-Ayyoubi S; Gali-Muhtasib H
    Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of PEA-15 reverses G1 arrest, and nuclear and chromatin changes of senescence phenotype via pErk1/2 translocation to nuclei.
    Lee YY; Kim HS; Lim IK
    Cell Signal; 2015 Jun; 27(6):1102-9. PubMed ID: 25725291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue].
    Levi Y; Barshack I; Avivi K; Bar-ILan D; Gutman M; Aderka D; Berger R; Yacobi R
    Harefuah; 2013 Jun; 152(6):326-9, 369. PubMed ID: 23885463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a computerized morphometry application for assessment of the tumor fraction in colon carcinoma tissue samples.
    Hershkovitz T; Shenhav A; Sabo E; Ben-Izhak O; Hershkovitz D
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):54-8. PubMed ID: 22595946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
    Escandell JM; Kaler P; Recio MC; Sasazuki T; Shirasawa S; Augenlicht L; Ríos JL; Klampfer L
    Biochem Pharmacol; 2008 Jul; 76(2):198-207. PubMed ID: 18561895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma.
    Benedix F; Meyer F; Kube R; Kropf S; Kuester D; Lippert H; Roessner A; Krüger S
    Pathol Res Pract; 2012 Oct; 208(10):592-7. PubMed ID: 22898351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
    Tahara H; Yasui W; Tahara E; Fujimoto J; Ito K; Tamai K; Nakayama J; Ishikawa F; Tahara E; Ide T
    Oncogene; 1999 Feb; 18(8):1561-7. PubMed ID: 10102626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of MAPK signal transduction proteins in an ischemia/reperfusion model of mouse intestine using in vivo cryotechnique.
    Chen J; Terada N; Saitoh Y; Huang Z; Ohno N; Ohno S
    Histochem Cell Biol; 2013 Oct; 140(4):491-505. PubMed ID: 23793953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.
    Fatrai S; van Schelven SJ; Ubink I; Govaert KM; Raats D; Koster J; Verheem A; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2015 Sep; 149(3):692-704. PubMed ID: 25962936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.
    Grøndahl-Hansen J; Ralfkiaer E; Kirkeby LT; Kristensen P; Lund LR; Danø K
    Am J Pathol; 1991 Jan; 138(1):111-7. PubMed ID: 1702928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
    Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
    Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.